They then investigated the correlation of these components with various tumor characteristics, including isocitrate dehydrogenase (IDH) mutation status (mutated versus wildtype), fluorescence visibility during surgery (graded as none, weak, or strong), 5-ALA dosage (single or double), and tumor margin type (solid tumor, infiltration zone, or reactive altered brain tissue). Here, IDH3A is linked to neoplasm.